Vitamin D deficiency in HIV-infected patients: Associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?

AIDS

Volumn 25, Issue 6, 2011, Pages 873-874

  Pasquet, Armelle ^a   Viget, Nathalie ^a   Ajana, Faiza ^a   De La Tribonniere, Xavier ^a   Dubus, Sandrine ^a   Paccou, Julien ^b   Legroux Gérot, Isabelle ^b   Melliez, Hugues ^a   Cortet, Bernard ^b   Yazdanpanah, Yazdan ^a,c  

^a CENTRE HOSPITALIER DE TOURCOING   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CYTOCHROME P450; EFAVIRENZ; ETRAVIRINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; TENOFOVIR; VITAMIN D;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MODEL; PRIORITY JOURNAL; SEASONAL VARIATION; SPRING; VITAMIN D DEFICIENCY; WINTER;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; HIV INFECTIONS; HIV-1; REVERSE TRANSCRIPTASE INHIBITORS; VITAMIN D DEFICIENCY;

EID: 79953761887     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834542fa     Document Type: Letter

References (8)

1. Mueller N, Fux C, Ledergerber B, Elzi L, Schmid P, Dang T, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24:1127-1134.
2. Welz T, Childs K, Ibrahim F, Poulton M, Taylor CB, Moniz CF, Post FA. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24:1923-1928.
3. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375-1382.
4. Rosenvinge MMM, Gedela KM, Copas AJP, Wilkinson AM, Sheehy CA, Bano GM, et al. Tenofovir-linked hyperparathyroidismis independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010; 54:496-499.
5. Yazdanpanah Y, Chêne G, Losina E, Goldie SJ, Merchadou LD, Alfandari S, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohort. Int J Epidemiol 2001; 30:864-871. (Pubitemid 32827397)
6. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25:9-14.
7. Brown T, Mc Comsey G. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitami D. Antivir Ther 2010; 15:425-429.
8. Landriscina M, Altamura SA, Roca L. Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear cell carcinoma. Int J Cancer 2008; 83:305-328.